171 related articles for article (PubMed ID: 10069109)
21. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
Merino Díaz L; Torres Sánchez MJ; Aznar Martín J
Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
[TBL] [Abstract][Full Text] [Related]
23. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
24. [Resistance to penicillin and other antimicrobials in 301 clinical isolates of Streptococcus pneumoniae].
Navarro C; Egido P; Aspiroz C; Durán E; García C; Rubio C; Gómez-Lus R
Enferm Infecc Microbiol Clin; 2000; 18(7):314-8. PubMed ID: 11109722
[TBL] [Abstract][Full Text] [Related]
25. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
[TBL] [Abstract][Full Text] [Related]
26. [Erythromycin resistance of group A beta-hemolytic streptococci isolated from patients with upper respiratory tract infections].
Yazgi H; Ertek M; Aktaş AE
Mikrobiyol Bul; 2002 Jan; 36(1):11-4. PubMed ID: 12476761
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
Castanheira M; Gales AC; Mendes RE; Jones RN; Sader HS
Clin Microbiol Infect; 2004 Jul; 10(7):645-51. PubMed ID: 15214878
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antimicrobial resistance of Streptococcus pneumoniae in Chinese children: four hospitals surveillance.
Shen X; Lu Q; Ye Q; Zhang G; Yu S; Zhang H; Deng Q; Yang Y
Chin Med J (Engl); 2003 Sep; 116(9):1304-7. PubMed ID: 14527353
[TBL] [Abstract][Full Text] [Related]
29. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
30. Group A streptococci: evaluation of in vitro resistance to two macrolides.
Millesimo M; Savoia D
Microbios; 1995; 82(332):141-7. PubMed ID: 7630322
[TBL] [Abstract][Full Text] [Related]
31. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
32. Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.
Bancescu G; Dumitriu S; Bancescu A; Pana M; Andrei M
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):1012-5. PubMed ID: 17438917
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Khan NW; Hassan F; Naqvi BS; Hasan SM
Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activity.
Marks MI; Rabinovitch M; MacKenzie R; Brazeau M
Can Med Assoc J; 1973 May; 108(10):1274-6. PubMed ID: 4488339
[TBL] [Abstract][Full Text] [Related]
35. Microbiologic activity of the newer macrolide antibiotics.
McCracken GH
Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
[TBL] [Abstract][Full Text] [Related]
36. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
García-de-Lomas J; Gimeno C; Millás E; Bermejo M; Lázaro MA; Navarro D; García-Ponte L; Garijo B
Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):11-3. PubMed ID: 9063666
[TBL] [Abstract][Full Text] [Related]
38. [Antibiotic susceptibility of group A beta hemolytic Streptococcus].
Cengiz AT; Kiyan M; Ciftçioğlu N
Mikrobiyol Bul; 1989 Apr; 23(2):163-73. PubMed ID: 2696867
[TBL] [Abstract][Full Text] [Related]
39. Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden.
Zackrisson G; Lind L; Roos K; Larsson P
Scand J Infect Dis; 1988; 20(4):419-20. PubMed ID: 3194710
[TBL] [Abstract][Full Text] [Related]
40. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study.
Cocuzza CE; Mattina R; Mazzariol A; Orefici G; Rescaldani R; Primavera A; Bramati S; Masera G; Parizzi F; Cornaglia G; Fontana R
Microb Drug Resist; 1997; 3(4):371-8. PubMed ID: 9442490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
